Literature DB >> 6966656

Suppression splenic T lymphocytes in human hepatosplenic Schistosomiasis mansoni.

J J Ellner, G R Olds, R Kamel, G S Osman, A el-Kholy, A A Mahmoud.   

Abstract

Splenic suppressor cell activity was evaluated in 10 patients with advanced hepatosplenic Schistosomiasis mansoni undergoing elective splenectomy. We used cell mixing experiments to assess the effect of mitomycin-C-treated spleen cells on antigen and mitogen-induced 3H-thymidine incorporation of responder cells. The suppressor to responder ratio was 1.0. Spleen cells from 7 of 10 patients caused at least 20% suppression of phytohemagglutinin-induced 3H-thymidine incorporation of one or more populations of responder cells (spleen cells, autologous and allogeneic peripheral blood mononuclear cells)Responses of peripheral blood mononuclear cells to streptokinase-streptodornase and schistosome soluble egg and worm antigen preparations also were inhibited by co-cultured spleen cells. An inverse correlation was apparent between the spleen cell response to PHA and the suppressor activity of that spleen cell population (r = -0.74, p less than 0.05). Cell purification procedures showed that the active suppressor splenic cell was non-adherent and rosetted neuraminidase-treated sheep erythrocytes. This splenic suppressor T lymphocyte may modulate splenic and peripheral blood lymphocyte responses in patients with hepatosplenic schistosomiasis.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6966656

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  10 in total

1.  Schistosoma japonicum egg antigen-specific T cell lines in man. Induction of helper and suppressor T cell lines and clones in vitro in a patient with chronic schistosomiasis japonica.

Authors:  N Ohta; T Itagaki; M Minai; K Hirayama; Y Hosaka
Journal:  J Clin Invest       Date:  1988-03       Impact factor: 14.808

2.  Effect of praziquantel on certain immune responses of schistosomal Egyptian patients. II. Cell-mediated lymphoproliferative response.

Authors:  A E el-Bassiouny; Z A Shaker; A H el-Kalouby; E H el-Raziky
Journal:  Parasitol Res       Date:  1987       Impact factor: 2.289

Review 3.  Immunopathology of Schistosoma mansoni infection.

Authors:  D L Boros
Journal:  Clin Microbiol Rev       Date:  1989-07       Impact factor: 26.132

4.  T-cell abnormality and defective interleukin-2 production in patients with carcinoma of the urinary bladder with schistosomiasis.

Authors:  S Raziuddin; S Shetty; A Ibrahim
Journal:  J Clin Immunol       Date:  1991-03       Impact factor: 8.317

5.  Relationship between intensity of infection and immunomodulation in human schistosomiasis. II. NK cell activity and in vitro lymphocyte proliferation.

Authors:  H Feldmeier; G A Gastl; U Poggensee; C Kortmann; A A Daffalla; H H Peter
Journal:  Clin Exp Immunol       Date:  1985-05       Impact factor: 4.330

6.  Immunogenetic analysis of patients with post-schistosomal liver cirrhosis in man.

Authors:  N Ohta; Y K Nishimura; M Iuchi; T Sasazuki
Journal:  Clin Exp Immunol       Date:  1982-09       Impact factor: 4.330

7.  Immunoregulatory function of human intestinal mucosa lymphoid cells: evidence for enhanced suppressor cell activity in inflammatory bowel disease.

Authors:  C Fiocchi; K R Youngman; R G Farmer
Journal:  Gut       Date:  1983-08       Impact factor: 23.059

8.  Failure of immunosuppressive mechanisms in human Schistosoma mansoni infection with hepatosplenomegaly.

Authors:  D J Tweardy; G S Osman; A el Kholy; J J Ellner
Journal:  J Clin Microbiol       Date:  1987-05       Impact factor: 5.948

9.  Schistosoma mekongi infection in man: cellular immune responses and modulating mechanisms.

Authors:  M Barral-Netto; M Hofstetter; J Gustavo dos Santos; A W Cheever; E A Ottesen
Journal:  Clin Exp Immunol       Date:  1982-01       Impact factor: 4.330

10.  Changes in T cell subsets and T suppressor cell function and their relationship in human schistosomiasis japonica.

Authors:  Z J Li; D D Luo; J Z Dai; L L Zheng; X H Wang; Y X Yang
Journal:  J Tongji Med Univ       Date:  1991
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.